Summarizing societal guidelines regarding bronchoscopy during the <scp>COVID</scp>‐19 pandemic

Lentz, Robert J.; Colt, Henri G.

doi:10.1111/resp.13824

Cited by 100 publications

(127 citation statements)

References 4 publications

Supporting

Mentioning

123

Contrasting

Unclassified

Order By: Relevance

“…16 The first American Association for Bronchology and Interventional Pulmonology statement was published in late March; in the following days, expert opinions on the use of bronchoscopy during the COVID-19 pandemic were published one after another. [17][18][19][20][21] While the use of PPE and bronchoscopy indications were similar between the published reports and our practice, not using negative pressure rooms, not testing all patients, using a reusable bronchoscope and only giving a 30-minute interval between the procedures are the notable differences between the reports and our practice. We proved that these differences did not cause any problems in the detection of COVID-19 in either patients and health care workers after the procedure.…”

Section: After Bronchoscopysupporting

confidence: 61%

Bronchoscopic procedures during COVID‐19 pandemic: Experiences in Turkey

Öztürk¹,

Şener²,

Yılmaz³

2020

Journal of Surgical Oncology

View full text Add to dashboard Cite

Background: Globally, coronavirus disease-2019 (COVID-19) is a new, highly contagious, and life-threatening virus. We aimed to demonstrate how we proceeded with bronchoscopic procedures without published guidelines at the inception of the pandemic period. Materials and Methods: All bronchoscopic procedures applied from the first case seen in Turkey (11 March-15 May) were evaluated retrospectively. Patient data on indications, diagnosis, types of procedures, and the results of COVID-19 tests were recorded. Results: This study included 126 patients; 36 required interventional bronchoscopic techniques (28.6%), 74 required endobronchial ultrasonography (EBUS; 58.7%), and 16 required flexible fiberoptic bronchoscopy (12.7%). All interventional rigid bronchoscopic techniques were performed for emergent indications: malignant airway obstruction (66.7%), tracheal stenosis (25%), and bronchopleural fistula (8.3%). Malignancy was diagnosed in 59 (79.7%), 12 (50%), and 4 (25%) patients who underwent EBUS, interventional procedures, and fibreoptic bronchoscopy, respectively. All personnel wore personal protective equipment and patients wore a surgical mask, cap, and disposable gown. Of the patients, 31 (24.6%) were tested for COVID-19 and all the results were negative. COVID-19 was not detected in any of the patients after a 14-day follow-up period. Conclusion: This study was based on our experiences and demonstrated that EBUS and/or bronchoscopy should not be postponed in patients with known or suspected lung cancer.

show abstract

Section: After Bronchoscopysupporting

confidence: 61%

Bronchoscopic procedures during COVID‐19 pandemic: Experiences in Turkey

Öztürk¹,

Şener²,

Yılmaz³

2020

Journal of Surgical Oncology

View full text Add to dashboard Cite

show abstract

“…They highlighted its portability, immediacy to start the procedure and the possibility of storing the images. (8)(9)(10)(11) However, these advantages would be of little value if the bronchoscope did not fulfill its functions with quality.…”

Section: Discussionmentioning

confidence: 99%

“…A disposable bronchoscope could decrease the risk of cross infection and increase accessibility to bronchoscopy in centers of less complexity or with limited resources and has been recommended by most respiratory societies for bronchoscopies during the SARS-COv-2 pandemic. (8)(9)(10)(11) Patients on mechanical ventilation, (12) immunosuppressed or with infectious contagious diseases are those with the highest risk for cross infections and where these devices may have a more relevant role. These bronchoscopes are also desirable for procedures with a high risk of damage the bronchoscope (e.g.…”

Section: )mentioning

confidence: 99%

Bronchoscopist's Perception of the Quality of the Single-use Fiberoptic Bronchoscope (Ambu Ascope4 ™) in Conventional Bronchoscopies. A Multicenter Study in 21 Spanish Pulmonology Services.

Aldeyturriaga

Giraldo

Alfayate

et al. 2020

Preprint

View full text Add to dashboard Cite

Background:The disposable bronchoscope is an excellent alternative to face the problem of SARS-CoV-2 and other cross infections, but the bronchoscopist's perception of its quality has not been evaluated. Methods: To evaluate the quality of the Ambu-aScope4 disposable bronchoscope, we carried out a cross-sectional study in 21 Spanish pulmonology services. We use a standardized questionnaire completed by the bronchoscopists at the end of each bronchoscopy. The variables were described with absolute and relative frequencies, measures of central tendency and dispersion depending on their nature. The existence of learning curves was evaluated by CUSUM analysis.Results:The most frequent indications in 300 included bronchoscopies was bronchial aspiration in 69.3% and the median duration of these was 9.1 minutes. The route of entry was nasal in 47.2% and oral in 34.1%. The average score for ease of use, image, and aspiration quality was 80/100. All the planned techniques were performed in 94.9% and the bronchoscopist was satisfied in 96.6% of the bronchoscopies. They highlighted the portability and immediacy of the aScope4TM to start the procedure in 99.3%, the possibility of taking and storing images in 99.3%. The CUSUM analysis showed average scores> 70/100 from the first procedure and from the 9th procedure more than 80% of the scores exceeded the 80/100 score.Conclusions:The aScope4 ™ scored well for ease of use, imaging, and aspiration. We found a learning curve with excellent scores from the 9th procedure. Bronchoscopists highlighted its portability, immediacy of use and the possibility of taking and storing images.

show abstract

“…Recently, bronchology societies published recommendations for the use of bronchoscopy during the pandemic. 11 Most guidelines recommend postponing elective bronchoscopy tests, but in the included hospitals, bronchoscopy was promptly performed on lung cancer-suspected patients. Although the guidelines recommend pre-test screening to identify those with fever, respiratory symptoms, and prior contact with COVID-19 patients, given that some COVID-19 patients are asymptomatic, uniform pre-bronchoscopy COVID-19 screening may be required in regions where community transmission of COVID-19 occurred.…”

Section: Preventive Measuresmentioning

confidence: 99%

Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea

Park

Lee

Kim

et al. 2020

Preprint

View full text Add to dashboard Cite

Background The COVID-19 pandemic is predicted to significantly affect patients with lung cancer, owing to its rapid progression and high mortality. Studies on lung cancer diagnosis and treatment during an epidemic are lacking. We analyzed the impact of COVID-19 on lung cancer diagnosis in Korea, where lung cancer incidence continues to rise.Methods The number of newly diagnosed lung cancer cases in three university-affiliated hospitals during the pandemic and their clinical features were compared with lung cancer cases diagnosed during the same period in the past three years. The effectiveness of measures taken by the study hospitals to prevent nosocomial transmission was reviewed.Results Between February and June during 2017–2020. 612 patients with lung cancer were diagnosed. During the pandemic, the number of patients who sought consultation at the division of pulmonology of study hospitals dropped by 16% from the previous year. Responding to the pandemic, the involved hospitals created physically isolated triage areas for patients with acute respiratory infection symptoms. Wide-range screening and preventive measures were implemented, thus minimizing delay in lung cancer diagnosis. No patients acquired COVID-19 due to hospital exposure. The proportion of patients with stage III–IV non-small-cell lung cancer (NSCLC) significantly increased (2020: 74.7% vs. 2017: 57.9%, 2018: 66.7%, 2019: 62.7%, p=0.011). The number of lung cancers diagnosed during this period and the previous year remained the same.Conclusion The proportion of patients with advanced NSCLC increased during the COVID-19 pandemic.

show abstract

Summarizing societal guidelines regarding bronchoscopy during the COVID‐19 pandemic

Cited by 100 publications

References 4 publications

Bronchoscopic procedures during COVID‐19 pandemic: Experiences in Turkey

Bronchoscopic procedures during COVID‐19 pandemic: Experiences in Turkey

Bronchoscopist's Perception of the Quality of the Single-use Fiberoptic Bronchoscope (Ambu Ascope4 ™) in Conventional Bronchoscopies. A Multicenter Study in 21 Spanish Pulmonology Services.

Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea

Contact Info

Product

Resources

About